SR
Sunil Rajkumar Sharma
About Sunil Rajkumar Sharma
Data last updated:
Sunil Rajkumar Sharma is a Director at Briskinn Solutions Private Limited (since 2020) and Director at Cytoskinn Pharma Private Limited (since 2024). The companies operate in Food And Beverages and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹10.52 Cr; the largest is Briskinn Solutions Private Limited at ₹7.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Sep 2020 | 2020 | ₹7.96 Cr (FY 2025) | Active | |
| Director | 08 Jul 2024 | 2024 | ₹2.56 Cr (FY 2025) | Active |
Board colleagues of Sunil Rajkumar Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kirankumar Harshadrai Dubal | 02484432 | Briskinn Solutions Private Limited , Cytoskinn Pharma Private Limited | Director |
| Kaushik Girdharbhai Bhanderi | 08876442 | Cytoskinn Pharma Private Limited | Director |
| Paawankumar Kirankumar Dubal | 10698943 | Cytoskinn Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Rajkumar Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Rajkumar Sharma
Sunil Rajkumar Sharma currently holds 2 directorships: Briskinn Solutions Private Limited (Director, since 12 Sep 2020, revenue ₹7.96 Cr (FY 2025)); Cytoskinn Pharma Private Limited (Director, since 08 Jul 2024, revenue ₹2.56 Cr (FY 2025)).
Sunil Rajkumar Sharma was first appointed on 12 Sep 2020 as Director at Briskinn Solutions Private Limited. The most recent appointment on record is 08 Jul 2024 at Cytoskinn Pharma Private Limited.
The 2 current companies of Sunil Rajkumar Sharma that report revenue have a combined latest revenue of ₹10.52 Cr: Briskinn Solutions Private Limited ₹7.96 Cr (FY 2025); Cytoskinn Pharma Private Limited ₹2.56 Cr (FY 2025).
The current boards of Sunil Rajkumar Sharma's companies include Kirankumar Harshadrai Dubal (Briskinn Solutions Private Limited), Kaushik Girdharbhai Bhanderi (Cytoskinn Pharma Private Limited), Paawankumar Kirankumar Dubal (Cytoskinn Pharma Private Limited).